Acarix AB (publ) (STO: ACARIX)

Market Cap	272.49M
Revenue	6.26M
Net Income	-70.95M
Shares Out	973.17M
EPS	-0.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,395,437
Open	0.282
Previous Close	0.282
Day's Range	0.278 - 0.294
52-Week Range	0.175 - 0.599
Beta	1.43
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease (CAD) rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 14
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ACARIX